Clinical and pathological characteristics of LRRK2 G2019S patients with PD. - Wikidata - wikimedia - TriplyDB

Clinical and pathological characteristics of LRRK2 G2019S patients with PD.

Clinical and pathological characteristics of LRRK2 G2019S patients with PD.

http://www.wikidata.org/entity/Q35911042

about

Progressive degeneration of human neural stem cells caused by pathogenic LRRK2 Interplay of LRRK2 with chaperone-mediated autophagy LRRK2 phosphorylates novel tau epitopes and promotes tauopathy Role of protein kinase A in regulating mitochondrial function and neuronal development: implications to neurodegenerative diseases High LRRK2 levels fail to induce or exacerbate neuronal alpha-synucleinopathy in mouse brain Cognitive profile of LRRK2-related Parkinson's disease Sequences located within the N-terminus of the PD-linked LRRK2 lead to increased aggregation and attenuation of 6-hydroxydopamine-induced cell death.Olfactory identification in LRRK2 G2019S mutation carriers: a relevant marker?Neuropsychological performance in LRRK2 G2019S carriers with Parkinson's disease Michael J. Fox Foundation LRRK2 Consortium: geographical differences in returning genetic research data to study participants.REM sleep behavior disorder, as assessed by questionnaire, in G2019S LRRK2 mutation PD and carriers.α-Synuclein oligomers and clinical implications for Parkinson disease.Divergent α-synuclein solubility and aggregation properties in G2019S LRRK2 Parkinson's disease brains with Lewy Body pathology compared to idiopathic cases.Cognitive and motor function in long-duration PARKIN-associated Parkinson disease.The neuropathology of genetic Parkinson's disease.Neurobiology of cognitive impairment in Parkinson's disease.LRRK2, a puzzling protein: insights into Parkinson's disease pathogenesis Neuropathology of genetic synucleinopathies with parkinsonism: Review of the literature.Targeted deletion of GD3 synthase protects against MPTP-induced neurodegeneration.

P2860

Q24301070-3863B32D-17D6-4E9F-B85D-DC04A4CADF76 Q24322747-33E0A720-F546-42E3-9A06-C282EF4C448C Q24338188-C36A8835-BDAD-4D80-B6C8-DC672EEF891B Q27021384-9380E1E2-4497-48C5-9D30-95265748B0F4 Q27303568-788CD4FE-090D-43A9-95D5-BBCE3856566C Q27333093-86D965F6-630D-43DF-9F2F-0FA40375BEBE Q34428227-72A040B0-73EE-4E6D-BE61-CED4FDF3E460 Q34562789-7FFFA23B-EEA8-4758-8019-2C4935B83D86 Q35013928-4F9A59A8-16B2-4F05-B9A4-83323553C7DC Q35219481-511566BB-2DDE-4C6A-8F65-89DD4D03FD86 Q36470291-0D557EE7-A3C7-4BC0-AFC8-B03EB97C55DE Q36718306-4B215B79-53EC-4C31-A4F0-4F639F84D952 Q37119983-D6265278-F858-423C-92E4-1BF3C5BE3736 Q37625797-AC03E87D-1A13-4A92-866D-A0F60B0D0040 Q37997386-9A63C111-6976-4E06-AD2E-8358A813103C Q38067143-0163451C-2951-473E-8BDF-B442AC121055 Q38218398-30417E7C-75D0-47E5-A64D-A6EEFEF1B1DA Q47619453-16539F83-8D64-49B5-ACB5-1638D9810F7E Q48046381-ACDAA7A6-C67A-432B-BE99-BBD6CBC387BD

P2860

Clinical and pathological characteristics of LRRK2 G2019S patients with PD.

http://www.wikidata.org/entity/Q35911042

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Clinical and pathological characteristics of LRRK2 G2019S patients with PD.

@ast

Clinical and pathological characteristics of LRRK2 G2019S patients with PD.

@en

type

label

Clinical and pathological characteristics of LRRK2 G2019S patients with PD.

@ast

Clinical and pathological characteristics of LRRK2 G2019S patients with PD.

@en

prefLabel

Clinical and pathological characteristics of LRRK2 G2019S patients with PD.

@ast

Clinical and pathological characteristics of LRRK2 G2019S patients with PD.

@en

P1433

Q35911042-BAB9A4B7-A711-46A2-9A01-59FEC9402123

P1476

Q35911042-B0AD1C52-5396-4B50-A150-1C34FE6C5CF8

P2093

Q35911042-081902CD-92BB-476A-845B-05B9921A1069

Q35911042-0B3D4C0E-81A3-4752-9E6B-A65A82B3F10D

Q35911042-292995DC-3AAE-435D-BB44-7A8AE71BBB27

Q35911042-39FF251C-70C7-4C27-9471-B210ECB32455

Q35911042-5E61373E-AEC2-4A83-8C6E-C7DE7322C382

Q35911042-64172AB6-F24F-4C90-B042-2339A7A1565A

Q35911042-991D7F4E-99FC-4C46-B3AB-800FF858F652

Q35911042-99F202DD-686A-4E6A-B47B-1A1952000DB4

Q35911042-A43BD21B-A468-4BD2-BE30-5D0EE0E9BA44

Q35911042-B72FB4E7-F8BE-47F2-AFA1-0E6A8A058705

P2860

Q35911042-06D9E55C-871C-4527-85BC-DBB44B518ACB

Q35911042-0AA6229C-DCF3-4F8A-852C-FFE3C89E2E2E

Q35911042-1D934D06-8BCA-42A2-A7B9-43C452A6C377

Q35911042-1F0EA491-E349-43ED-A75F-D0ACCEFA5DBB

Q35911042-24B6D64D-A8EC-49CD-97A4-C5588AABE7E5

Q35911042-38E13EBC-C677-40D0-BA01-6D5DE1DA8498

Q35911042-40937E59-CC8C-47E3-AB8F-D0D90572F873

Q35911042-5B39A6A7-7964-4AAA-8333-A903CC577633

Q35911042-6D49A3CD-AAC6-4B53-A299-8173B4AB9627

Q35911042-6FF49790-DBD1-4165-A2E5-AF1DAF996CFE

P2888

Q35911042-25694DBA-0213-4F69-B6C6-CC8211B625D5

P304

Q35911042-F7F2BB45-3ED2-494F-AE43-868C27815570

P31

Q35911042-C72FA1B3-C4B4-4D10-B32D-C793753B8F4C

P356

Q35911042-AE5839C1-31B6-4DAE-AC26-DEEE30611F5B

P433

Q35911042-137FA4BE-7E0E-4C1D-83E3-1289D4765ECB

P478

Q35911042-364FE154-B39C-4233-89A6-D0AC9CB10B6B

P50

Q35911042-832BF4E2-4754-47AD-B772-985BC78C5B9D

P577

Q35911042-B1B8F614-FD44-4957-886D-2D6ACCD56A32

P5875

Q35911042-23743141-97EE-4FF5-AA46-4173E7F4FDCE

P698

Q35911042-69E3E4F9-829C-4FDF-9F14-5BDA00050FBB

P932

Q35911042-3BCD1F1B-546F-40DE-8349-230EE6522815

P356

S12031-011-9696-Y

P1433

Journal of Molecular Neuroscience

P1476

Clinical and pathological characteristics of LRRK2 G2019S patients with PD.

@en

P2093

Carol Moskowitz

http://www.w3.org/2001/XMLSchema#string

Cheryl Waters

http://www.w3.org/2001/XMLSchema#string

Etty Cortes

http://www.w3.org/2001/XMLSchema#string

Jean-Paul G Vonsattel

http://www.w3.org/2001/XMLSchema#string

Karen S Marder

http://www.w3.org/2001/XMLSchema#string

Lawrence S Honig

http://www.w3.org/2001/XMLSchema#string

Lorraine N Clark

http://www.w3.org/2001/XMLSchema#string

Lucien J Cote

http://www.w3.org/2001/XMLSchema#string

Markos Poulopoulos

http://www.w3.org/2001/XMLSchema#string

Roy N Alcalay

http://www.w3.org/2001/XMLSchema#string

P2860

Staging of brain pathology related to sporadic Parkinson's disease

Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology

A common LRRK2 mutation in idiopathic Parkinson's disease

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study

Hyposmia in G2019S LRRK2-related parkinsonism: clinical and pathologic data.

Parkinson's Disease Society Brain Bank, London: overview and research.

Leucine-rich repeat kinase 2 gene-associated disease: redefining genotype-phenotype correlation

Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study.

G2019S LRRK2 mutation causing Parkinson's disease without Lewy bodies

P2888

s12031-011-9696-y

P304

139-143

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12031-011-9696-Y

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

47

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-12-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51920346

http://www.w3.org/2001/XMLSchema#string

P698

22194196

http://www.w3.org/2001/XMLSchema#string

P932

3335886

http://www.w3.org/2001/XMLSchema#string